关注
Shravya Vinnakota
Shravya Vinnakota
Department of Cardiovascular Diseases, Mayo Clinic
在 mayo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
The importance of natriuretic peptides in cardiometabolic diseases
S Vinnakota, HH Chen
Journal of the Endocrine Society 4 (6), bvaa052, 2020
552020
Role of stress and psychosocial determinants on women's cardiovascular risk and disease development
JR Medina-Inojosa, S Vinnakota, M Garcia, M Arciniegas Calle, ...
Journal of women's health 28 (4), 483-489, 2019
312019
Estimated glomerular filtration rate, activation of cardiac biomarkers and long-term cardiovascular outcomes: a population-based cohort
S Vinnakota, CG Scott, RJ Rodeheffer, HH Chen
Mayo Clinic Proceedings 94 (11), 2189-2198, 2019
142019
Stress management and resilience intervention in a women's heart clinic: a pilot study
A Bhagra, JR Medina-Inojosa, S Vinnakota, MC Arciniegas, M Garcia, ...
Journal of women's health 28 (12), 1705-1710, 2019
112019
Thrombolysis for COVID-19-associated bioprosthetic mitral valve thrombosis with shock
S Vinnakota, JC Jentzer, SA Luis
European heart journal 42 (39), 4093-4093, 2021
82021
Hydroxychloroquine cardiomyopathy in a patient with gene positive hypertrophic cardiomyopathy
S Vinnakota, M van Zyl, J Geske
Journal of the American College of Cardiology 73 (9S1), 2148-2148, 2019
42019
Linear IgA bullous dermatosis: A rare manifestation of vancomycin hypersensitivity
S Vinnakota, BR Salonen
Annals of Allergy, Asthma & Immunology 120 (1), 101-102, 2018
42018
Neurohumoral activation and long-term cardiovascular outcomes in chronic kidney disease: a population-based cohort
S Vinnakota, C Scott, R Rodeheffer, H Chen
Journal of the American College of Cardiology 69 (11S), 930-930, 2017
42017
Multimodal Imaging in Mycobacterium Chimaera Cardiovascular Infections: The Mayo Clinic Experience
S Vinnakota, AD Tarabochia, NY Tan, WR Miranda, LJ Sinak, ...
Mayo Clinic Proceedings: Innovations, Quality & Outcomes 8 (4), 396-405, 2024
12024
The Cardiorenal Effects of Chronic Phosphodiesterase-V Inhibition in Preclinical Diastolic Dysfunction (Stage B Heart Failure)
S Vinnakota, FW Adel, PM McKie, CG Scott, HH Chen
Journal of Cardiac Failure 29 (10), 1461-1465, 2023
2023
Right Ventricular Involvement In Wild-type Transthyretin Cardiac Amyloidosis
S Vinnakota, MT Ali, IC Chang
Journal of Cardiac Failure 29 (4), 701, 2023
2023
STEMI IN COVID-19: NOT ALWAYS A MIMIC!
S Vinnakota, CE Bennett
Journal of the American College of Cardiology 79 (9_Supplement), 2360-2360, 2022
2022
Radiation-induced Accelerated Multi-valve Disease In A Patient With Subaortic Membrane
M Garcia-Arango, S Vinnakota, HR Villarraga
Circulation 144 (Suppl_2), A17189-A17189, 2021
2021
THE CARDIORENAL EFFECTS OF CHRONIC PHOSPHODIESTERASE V INHIBITION IN PRECLINICAL DIASTOLIC DYSFUNCTION (STAGE B HEART FAILURE)
S Vinnakota, C Scott, H Chen
Journal of the American College of Cardiology 77 (18_Supplement_1), 804-804, 2021
2021
A rare case of infective endocarditis in a quadricuspid aortic valve caused by Gemella sanguinis
NVT Ji H, Vinnakota S, Wilson WR
Discussion of Clinical Cases 7 (3), 2021
2021
57-Year-Old Man With Vertigo
S Vinnakota, K Sharain, RD McBane
Mayo Clinic Proceedings 94 (6), e73-e79, 2019
2019
VERTEBRAL ARTERY DISSECTION: HIDDEN IN PLAIN SIGHT
S Vinnakota, K Sharain
JOURNAL OF GENERAL INTERNAL MEDICINE 33, S654-S655, 2018
2018
A RARE CASE OF PLATYPNEA-ORTHODEOXIA IN A PATIENT WITH PFO
S Vinnakota, DF Kupsky, SH Wan, W Miranda, CS Rihal
CARDIOLOGY 131, 311-311, 2015
2015
A rare case of infective endocarditis in a quadricuspid aortic valve caused by Gemella sanguinis
H Ji, S Vinnakota, WR Wilson, VT Nkomo
系统目前无法执行此操作,请稍后再试。
文章 1–19